Precision medicine and the future of cardiovascular diseases: a clinically oriented comprehensive review

Y Sethi, N Patel, N Kaka, O Kaiwan, J Kar… - Journal of clinical …, 2023 - mdpi.com
Cardiac diseases form the lion's share of the global disease burden, owing to the paradigm
shift to non-infectious diseases from infectious ones. The prevalence of CVDs has nearly …

Redefining the identity of cardiac fibroblasts

MD Tallquist, JD Molkentin - Nature Reviews Cardiology, 2017 - nature.com
Cardiac fibroblasts deposit and maintain extracellular matrix during organogenesis and
under physiological conditions. In the adult heart, activated cardiac fibroblasts also …

Extracellular matrix remodeling and cardiac fibrosis

L Li, Q Zhao, W Kong - Matrix biology, 2018 - Elsevier
Cardiac fibrosis, characterized by excessive deposition of extracellular matrix (ECM)
proteins in the myocardium, distorts the architecture of the myocardium, facilitates the …

Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications

MS Dzeshka, GYH Lip, V Snezhitskiy… - Journal of the American …, 2015 - jacc.org
Atrial fibrillation (AF) is associated with structural, electrical, and contractile remodeling of
the atria. Development and progression of atrial fibrosis is the hallmark of structural …

Galectin-3 as a next-generation biomarker for detecting early stage of various diseases

A Hara, M Niwa, K Noguchi, T Kanayama, A Niwa… - Biomolecules, 2020 - mdpi.com
Galectin-3 is a β-galactoside-binding lectin which is important in numerous biological
activities in various organs, including cell proliferation, apoptotic regulation, inflammation …

Current understanding of the pathophysiology of myocardial fibrosis and its quantitative assessment in heart failure

T Liu, D Song, J Dong, P Zhu, J Liu, W Liu, X Ma… - Frontiers in …, 2017 - frontiersin.org
Myocardial fibrosis is an important part of cardiac remodeling that leads to heart failure and
death. Myocardial fibrosis results from increased myofibroblast activity and excessive …

[HTML][HTML] The therapeutic potential of galectin-3 inhibition in fibrotic disease

RJ Slack, R Mills, AC Mackinnon - … Journal of Biochemistry & Cell Biology, 2021 - Elsevier
Galectin-3 is a beta-galactoside-binding mammalian lectin and part of the 15 member
galectin family that are evolutionarily highly conserved. It is the only chimeric protein with a …

Galectin-3 mediates aldosterone-induced vascular fibrosis

L Calvier, M Miana, P Reboul… - … , and vascular biology, 2013 - ahajournals.org
Objective—Aldosterone (Aldo) is involved in arterial stiffness and heart failure, but the
mechanisms have remained unclear. Galectin-3 (Gal-3), a β-galactoside-binding lectin …

Atrial remodeling, fibrosis, and atrial fibrillation

J Jalife, K Kaur - Trends in cardiovascular medicine, 2015 - Elsevier
The fundamental mechanisms governing the perpetuation of atrial fibrillation (AF), the most
common arrhythmia seen in clinical practice, are poorly understood, which explains in part …

Functions of galectin-3 and its role in fibrotic diseases

L Li, J Li, J Gao - The Journal of pharmacology and experimental …, 2014 - Elsevier
Fibrotic diseases occur in a variety of organs and lead to continuous organ injury, function
decline, and even failure. Currently effective treatment options are limited. Galectin-3 (Gal-3) …